Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_provenance.
- NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_assertion description "[We identified the glycogen debranching enzyme AGL as a prognostic indicator of patient survival (P = .04) and as a novel regulator of bladder cancer anchorage-dependent (P < .001), anchorage-independent (mean � standard deviation, 180 � 23.1 colonies vs 20�9.5 in control, P < .001), and xenograft growth (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_provenance.
- NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_assertion evidence source_evidence_literature NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_provenance.
- NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_assertion SIO_000772 24700805 NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_provenance.
- NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_assertion wasDerivedFrom befree-20150227 NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_provenance.
- NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_assertion wasGeneratedBy ECO_0000203 NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP228422.RA2vHCS2InfcgONs_vZU5ztjUuuO-Y2QoTN6768vRZ6IU130_provenance.